Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 10-Jul-23 7:36 PM View:  | Fibrogen Inc (FGEN) | 07-Jul-23 | Sale | 1,880 | $2.80 | $5,264.00 | (< 1%) 404.4K to 402.52K | |
| 09-Jun-23 7:10 PM View: | Fibrogen Inc (FGEN) | 07-Jun-23 | Private Sale | 8,897 | $17.04 | $151,583.00 | (2%) 413.3K to 404.4K | |
| 11-Apr-23 4:59 PM View: | Fibrogen Inc (FGEN) | 10-Apr-23 | Private Sale | 1,869 | $19.52 | $36,482.90 | (< 1%) 412.67K to 410.8K | |
| 10-Mar-23 9:55 PM View: | Fibrogen Inc (FGEN) | 10-Mar-23 | Sale | 31,589 | $20.20 | $638,012.00 | (7%) 444.26K to 412.67K | |
| 10-Mar-23 9:55 PM View: | Fibrogen Inc (FGEN) | 08-Mar-23 | Grant | 60,349 | -- | -- | 15% 408.58K to 468.93K | |
| 10-Mar-23 9:55 PM View: | Fibrogen Inc (FGEN) | 08-Mar-23 | Sale | 24,672 | $21.16 | $521,958.00 | (5%) 468.93K to 444.26K | |
| 23-Feb-23 8:29 PM View: | Fibrogen Inc (FGEN) | 21-Feb-23 | Grant | 85,300 | -- | -- | 26% 323.28K to 408.58K | |
| 10-Jan-23 4:46 PM View: | Fibrogen Inc (FGEN) | 06-Jan-23 | Private Sale | 1,538 | $19.95 | $30,683.10 | (< 1%) 324.82K to 323.28K | |
| 09-Dec-22 7:19 PM View: | Fibrogen Inc (FGEN) | 08-Dec-22 | Private Sale | 2,543 | $15.79 | $40,154.00 | (< 1%) 327.36K to 324.82K | |
| 11-Oct-22 5:06 PM View: | Fibrogen Inc (FGEN) | 06-Oct-22 | Payment of Exercise | 1,296 | $14.26 | $18,481.00 | (< 1%) 328.66K to 327.36K | 3% |
| 08-Sep-22 6:53 PM View: | Fibrogen Inc (FGEN) | 06-Sep-22 | Payment of Exercise | 1,772 | $12.26 | $21,724.70 | (< 1%) 330.43K to 328.66K | (13%) |
| 08-Jul-22 4:42 PM View: | Fibrogen Inc (FGEN) | 06-Jul-22 | Payment of Exercise | 1,296 | $12.40 | $16,070.40 | (< 1%) 331.73K to 330.43K | (12%) |
| 08-Jun-22 7:23 PM View: | Fibrogen Inc (FGEN) | 06-Jun-22 | Payment of Exercise | 1,772 | $9.50 | $16,834.00 | (< 1%) 331.51K to 329.74K | |
| 08-Apr-22 4:07 PM View: | Fibrogen Inc (FGEN) | 07-Apr-22 | Payment of Exercise | 1,311 | $12.73 | $16,689.00 | (< 1%) 332.82K to 331.51K | (9%) |
| 09-Mar-22 5:43 PM View: | Fibrogen Inc (FGEN) | 07-Mar-22 | Payment of Exercise | 7,081 | $12.69 | $89,857.90 | (2%) 339.9K to 332.82K | (9%) |
| 16-Feb-22 8:57 PM View: | Fibrogen Inc (FGEN) | 14-Feb-22 | Grant | 179,400 | -- | -- | 112% 160.5K to 339.9K | |
| 07-Jan-22 5:37 PM View: | Fibrogen Inc (FGEN) | 06-Jan-22 | Payment of Exercise | 1,536 | $13.93 | $21,396.50 | (< 1%) 162.04K to 160.5K | 0% |
| 08-Oct-21 5:03 PM View: | Fibrogen Inc (FGEN) | 06-Oct-21 | Payment of Exercise | 1,859 | $10.20 | $18,961.80 | (1%) 163.9K to 162.04K | (1%) |
| 08-Jul-21 8:31 PM View: | Fibrogen Inc (FGEN) | 06-Jul-21 | Payment of Exercise | 1,859 | $25.06 | $46,586.50 | (1%) 165.76K to 163.9K | 43% |
| 26-Feb-21 7:19 PM View: | Fibrogen Inc (FGEN) | 24-Feb-21 | Grant | 82,000 | -- | -- | 99% 83.07K to 165.07K | |
| 08-Jan-21 7:40 PM View: | Fibrogen Inc (FGEN) | 06-Jan-21 | Payment of Exercise | 5,411 | $38.31 | $207,295.00 | (6%) 88.48K to 83.07K | 63% |
| 12-Jun-20 6:59 AM View: | Fibrogen Inc (FGEN) | 11-Jun-20 | Market Purchase | 19,800 | $35.28 | $698,599.00 | 29% 68.0K to 87.8K | (59%) |
| 12-Jun-20 6:59 AM View: | Fibrogen Inc (FGEN) | 10-Jun-20 | Market Purchase | 8,000 | $36.29 | $290,282.00 | 13% 60.0K to 68.0K | (60%) |
| 08-Jan-20 9:10 PM View: | Fibrogen Inc (FGEN) | 06-Jan-20 | Grant | 60,000 | -- | -- | 100% 0 to 60.0K | |
| 20-Feb-19 3:37 PM View: | Eli Lilly & Co. (LLY) | 15-Feb-19 | Market Sale (Planned) | 25,000 | $121.00 | $3,025,000.00 | (15%) 163.12K to 138.12K | (36%) |
| 06-Feb-19 7:02 PM View: | Eli Lilly & Co. (LLY) | 04-Feb-19 | Grant | 26,681 | $120.17 | $3,206,260.00 | 20% 136.44K to 163.12K | 36% |
| 05-Feb-19 6:49 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-19 | Payment of Exercise | 5,476 | $119.86 | $656,353.00 | (4%) 141.91K to 136.44K | (36%) |
| 05-Feb-19 6:49 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-19 | Option Exercise | 12,222 | -- | -- | 9% 129.69K to 141.91K | |
| 01-Jun-18 4:22 PM View: | Eli Lilly & Co. (LLY) | 31-May-18 | Market Sale (Planned) | 25,000 | $85.00 | $2,125,000.00 | (16%) 154.62K to 129.62K | (90%) |
| 03-May-18 4:26 PM View: | Eli Lilly & Co. (LLY) | 01-May-18 | Payment of Exercise | 8,934 | $81.07 | $724,279.00 | (5%) 163.55K to 154.62K | (98%) |
| 03-May-18 4:26 PM View: | Eli Lilly & Co. (LLY) | 01-May-18 | Option Exercise | 20,000 | -- | -- | 14% 143.55K to 163.55K | |
| 05-Feb-18 6:12 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-18 | Payment of Exercise | 9,512 | $81.45 | $774,752.00 | (6%) 153.03K to 143.52K | (96%) |
| 05-Feb-18 6:12 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-18 | Option Exercise | 21,326 | -- | -- | 16% 131.7K to 153.03K | |
| 31-Jan-18 5:57 PM View: | Eli Lilly & Co. (LLY) | 29-Jan-18 | Grant | 12,437 | $87.60 | $1,089,480.00 | 10% 119.26K to 131.7K | 82% |
| 08-May-17 3:44 PM View: | Eli Lilly & Co. (LLY) | 04-May-17 | Market Sale | 25,000 | $82.76 | $2,069,000.00 | (17%) 144.17K to 119.17K | (91%) |
| 03-Feb-17 2:35 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-17 | Payment of Exercise | 4,810 | $77.03 | $370,514.00 | (3%) 148.95K to 144.14K | (107%) |
| 03-Feb-17 2:35 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-17 | Option Exercise | 10,244 | -- | -- | 7% 138.71K to 148.95K | |
| 31-Jan-17 5:51 PM View: | Eli Lilly & Co. (LLY) | 27-Jan-17 | Grant | 20,211 | $75.38 | $1,523,510.00 | 17% 118.5K to 138.71K | 112% |
| 03-Feb-16 1:46 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-16 | Payment of Exercise | 4,872 | $79.10 | $385,375.00 | (4%) 123.23K to 118.36K | (107%) |
| 03-Feb-16 1:46 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-16 | Option Exercise | 10,360 | -- | -- | 9% 112.87K to 123.23K | |
| 28-Jan-16 6:45 PM View: | Eli Lilly & Co. (LLY) | 26-Jan-16 | Grant | 19,953 | $81.96 | $1,635,350.00 | 21% 92.92K to 112.87K | 100% |
| 10-Dec-15 2:09 PM View: | Eli Lilly & Co. (LLY) | 09-Dec-15 | Market Sale | 25,000 | $83.88 | $2,097,000.00 | (21%) 117.92K to 92.92K | (95%) |
| 16-Nov-15 3:51 PM View: | Eli Lilly & Co. (LLY) | 12-Nov-15 | Payment of Exercise | 5,579 | $80.70 | $450,225.00 | (5%) 123.47K to 117.89K | (103%) |
| 16-Nov-15 3:51 PM View: | Eli Lilly & Co. (LLY) | 12-Nov-15 | Option Exercise | 6,928 | $56.18 | $389,215.00 | 6% 116.55K to 123.47K | |
| 03-Feb-15 3:50 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-15 | Payment of Exercise | 6,608 | $72.00 | $475,776.00 | (5%) 123.07K to 116.46K | (133%) |
| 03-Feb-15 3:50 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-15 | Option Exercise | 13,990 | -- | -- | 13% 109.08K to 123.07K | |
| 30-Jan-15 5:12 PM View: | Eli Lilly & Co. (LLY) | 28-Jan-15 | Grant | 30,037 | $70.97 | $2,131,730.00 | 38% 79.04K to 109.08K | 137% |
| 12-Dec-14 5:06 PM View: | Eli Lilly & Co. (LLY) | 10-Dec-14 | Payment of Exercise | 6,046 | $72.21 | $436,582.00 | (7%) 84.52K to 78.47K | (133%) |
| 12-Dec-14 5:06 PM View: | Eli Lilly & Co. (LLY) | 10-Dec-14 | Option Exercise | 7,101 | $55.65 | $395,171.00 | 9% 77.42K to 84.52K | |
| 04-Nov-14 3:08 PM View: | Eli Lilly & Co. (LLY) | 03-Nov-14 | Market Sale (Planned) | 5,000 | $66.03 | $330,150.00 | (6%) 77.74K to 72.74K | (156%) |